IL10 and asthma: Likewise, targeting MDSCs/IL-10 directly or indirectly in other pathological conditions such as sepsis/infection [112,113], certain autoimmune disorders, and certain allergic disorders such as asthma [125] could also provide a promising approach to control such pathological conditions.